EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Docetaxel response in BRCA1,p53-deficient mammary tumor cells is affected by Huntingtin and BAP1

Martín González-Fernández iD, Carmen Perry iD, Nora Merete Gerhards, Paola Francica, Sven Rottenberg iD

Proceedings of the National Academy of Sciences · 2024

DOI: 10.1073/pnas.2402849121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Martín González-Fernández und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Pathobiology, Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland. Hauptthemen laut MEDLINE: Docetaxel, BRCA1 Protein, Tumor Suppressor Proteins, Ubiquitin Thiolesterase. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF), Krebsliga Schweiz (Swiss Cancer League), EC | European Research Council (ERC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Taxanes are frequently used anticancer drugs known to kill tumor cells by inducing mitotic aberrations and segregation defects. A defining feature of specific cancers, notably triple-negative breast cancer (TNBC) and particularly those deficient in BRCA1, is chromosomal instability (CIN). Here, we focused on understanding the mechanisms of docetaxel-induced cytotoxicity, especially in the context of BRCA1-deficient TNBC. Using functional genetic screens in CIN+ cells, we identified genes that mediate docetaxel response and found an interaction between Huntingtin (HTT) and BRCA1-associated protein-1 (BAP1). We employed Brca1 −/− ; p53 − /− mammary tumor cells, derived from genetically engineered mouse tumors that closely mimic the human disease, to investigate the role of these genes in CIN+ BRCA1-deficient cells. Specifically, we observed that loss of HTT sensitizes CIN+ BRCA1-deficient mammary tumor cells to docetaxel by shortening mitotic spindle poles and increasing spindle multipolarity. In contrast, BAP1 depletion protected cells against these spindle aberrations by restoring spindle length and enhancing mitotic clustering of the extra centrosomes. In conclusion, our findings shed light on the roles of HTT and BAP1 in controlling mitotic spindle multipolarity and centrosome clustering, specifically in the absence of BRCA1. This affects the response to microtubule-targeting agents and suggests that further studies of the interaction of these genes with the mitotic spindle may provide useful insights into how to target CIN+ cells, particularly in the challenging therapeutic landscape of BRCA1-deficient TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DocetaxelBRCA1 ProteinTumor Suppressor ProteinsUbiquitin ThiolesteraseHuntingtin ProteinTumor Suppressor Protein p53Triple Negative Breast NeoplasmsAnimalsMiceFemaleHumansSpindle ApparatusCell Line, TumorChromosomal InstabilityAntineoplastic Agents

Stichwörter der Autor:innen

BRCA1Huntingtinchromosomal instabilitytaxanestriple negative breast cancer

Substanzen

DocetaxelBRCA1 ProteinTumor Suppressor ProteinsUbiquitin ThiolesteraseHuntingtin ProteinTumor Suppressor Protein p53BRCA1 protein, humanBAP1 protein, mouseAntineoplastic AgentsHtt protein, mouse

Autor:innen und Institutionen

  • Department of Infectious Diseases and Pathobiology, Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland.
  • Bern Center for Precision Medicine, Department of Biomedical Research, University of Bern, 3012 Bern, Switzerland.

ORCID-Profile: Martín González-Fernández, Carmen Perry, Sven Rottenberg

Förderung

  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF)
  • Krebsliga Schweiz (Swiss Cancer League)
  • EC | European Research Council (ERC)

Zitieren

APA

González-Fernández, M., Perry, C., Gerhards, N. M., Francica, P., & Rottenberg, S. (2024). Docetaxel response in BRCA1,p53-deficient mammary tumor cells is affected by Huntingtin and BAP1. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2402849121

Vancouver

González-Fernández M, Perry C, Gerhards NM, Francica P, Rottenberg S. Docetaxel response in BRCA1,p53-deficient mammary tumor cells is affected by Huntingtin and BAP1. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2402849121

BibTeX
@article{GonzlezFernndez2024,
  author = {González-Fernández, Martín and Perry, Carmen and Gerhards, Nora Merete and Francica, Paola and Rottenberg, Sven},
  title = {Docetaxel response in BRCA1,p53-deficient mammary tumor cells is affected by Huntingtin and BAP1},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  doi = {10.1073/pnas.2402849121}
}
Kostenlos starten →